Insights

Growth Momentum Wockhardt is reporting robust quarterly growth with total income up about 26% year over year and a similar rise in revenue, indicating expanding market demand and potential for higher-volume partnerships in APIs, formulations, and vaccines.

Global Footprint With operations in the US, UK, Ireland, France and a diversified emerging markets presence, there are multiple regional entry points for collaboration, contract manufacturing, and supply agreements tailored to local regulatory and market needs.

Antibiotic Focus The launch of Antibiotic Academy signals a strategic emphasis on education and thought leadership around antibiotics; potential for partnerships in clinical education programs, co-marketing vaccine and antimicrobial products, and investigator-initiated trials.

Novel Therapies Development of Zaynich and WCK 6777 positions Wockhardt in advanced antimicrobial therapeutics; opportunities exist for licensing, co-development, or supply agreements in hospital and outpatient settings facing antimicrobial resistance challenges.

Healthcare Ecosystem As a multi-channel healthcare enterprise spanning pharmaceuticals, biotechnology, and super specialty hospitals, Wockhardt presents cross-selling opportunities across APIs, finished formulations, vaccines, and integrated care services in both mature and emerging markets.

Similar companies to Wockhardt Ltd.

Wockhardt Ltd. Tech Stack

Wockhardt Ltd. uses 8 technology products and services including SAP FICO, SAP Financial Management, jsDelivr, and more. Explore Wockhardt Ltd.'s tech stack below.

  • Accounting
  • SAP Financial Management
    Accounting And Finance
  • jsDelivr
    Content Delivery Network
  • Content Management System
  • oEmbed
    Dev Tools
  • E-commerce
  • Priority Hints
    Performance
  • Plesk
    Web Hosting

Media & News

Wockhardt Ltd.'s Email Address Formats

Wockhardt Ltd. uses at least 4 email formats:
Wockhardt Ltd. Email FormatsExamplePercentage
FLast@wockhardt.comJDoe@wockhardt.com
96%
First.Last@wockhardt.comJohn.Doe@wockhardt.com
3%
FL@wockhardt.comJD@wockhardt.com
1%
FLast@mgp-online.comJDoe@mgp-online.com
100%

Frequently Asked Questions

What is Wockhardt Ltd.'s phone number?

Minus sign iconPlus sign icon
You can contact Wockhardt Ltd.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Wockhardt Ltd.'s stock symbol?

Minus sign iconPlus sign icon
Wockhardt Ltd. is a publicly traded company; the company's stock symbol is WOCKPHARMA.NS.

What is Wockhardt Ltd.'s official website and social media links?

Minus sign iconPlus sign icon
Wockhardt Ltd.'s official website is wockhardt.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Wockhardt Ltd. generate?

Minus sign iconPlus sign icon
As of October 2026, Wockhardt Ltd.'s annual revenue is estimated to be $250M - $500M.

What is Wockhardt Ltd.'s SIC code and NAICS code?

Minus sign iconPlus sign icon
Wockhardt Ltd.'s SIC code is 2835 - In Vitro and In Vivo Diagnostic Substances and NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Wockhardt Ltd. have currently?

Minus sign iconPlus sign icon
As of October 2026, Wockhardt Ltd. has approximately 7.6K employees across 6 continents, including Asia, Europe and North America. Key team members include Ceo: H. K., Ceo Wockhardt Uk: R. L. O. and Chief Executive Officer: N. T. Explore Wockhardt Ltd.'s employee directory with LeadIQ.

What industry does Wockhardt Ltd. belong to?

Minus sign iconPlus sign icon
Wockhardt Ltd. operates in the Pharmaceutical Manufacturing industry.

What technology does Wockhardt Ltd. use?

Minus sign iconPlus sign icon
Wockhardt Ltd.'s tech stack includes SAP FICO, SAP Financial Management, jsDelivr, WordPress, oEmbed, Shopify, Priority Hints and Plesk.

What is Wockhardt Ltd.'s email format?

Minus sign iconPlus sign icon
Wockhardt Ltd.'s email format typically follows the pattern of FLast@wockhardt.com. Find more Wockhardt Ltd. email formats with LeadIQ.

How much funding has Wockhardt Ltd. raised to date?

Minus sign iconPlus sign icon
As of October 2026, Wockhardt Ltd. has raised $12M in funding. The last funding round occurred on Mar 19, 2024 for $12M.
Wockhardt Ltd. logo

Wockhardt Ltd.

Pharmaceutical ManufacturingMaharashtra, India5001-10000 Employees

Wockhardt Ltd. is a global pharmaceutical and biotechnology company headquartered in Mumbai, with an operational base in Bandra, Maharashtra. It develops and manufactures medicines and biopharmaceutical products, including formulations, active pharmaceutical ingredients and vaccines, and operates a chain of advanced super-specialty hospitals. The company has a multinational footprint with full-fledged operations in the USA, the UK, Ireland and France, and markets its products across a broad range of emerging markets. 

Its core capabilities span three research centers and twelve manufacturing plants, supported by a diverse workforce. Wockhardt emphasizes innovation as its guiding strategy, applying scientific advances to improve health outcomes. In 2026, the company disclosed progress on WCK 6777, a once-daily antibiotic in development following FDA approval of Zaynich, illustrating ongoing pipeline activity for outpatient treatment markets.

Section iconCompany Overview

Phone number
SIC Code
2835 - In Vitro and In Vivo Diagnostic Substances
Stock Symbol
WOCKPHARMA.NS
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
5001-10000

Section iconFunding & Financials

  • $12M

    Wockhardt Ltd. has raised a total of $12M of funding over 2 rounds. Their latest funding round was raised on Mar 19, 2024 in the amount of $12M as a Post IPO Debt.

  • $250M - $500M

    Wockhardt Ltd.'s revenue is estimated to be in the range of $250M - $500M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.